{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:21:41Z","timestamp":1768609301597,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-026-06206-6","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T13:10:22Z","timestamp":1768569022000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictive factors for negative prostate biopsy in PI-RADS 5 patients: a multivariate analysis of clinical and imaging-based factors"],"prefix":"10.1007","volume":"44","author":[{"given":"Cristian","family":"Acevedo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Sebasti\u00e1n","family":"Arroyave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Saldivia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohit","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Moya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisca","family":"Larenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"6206_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-023-04578-7","author":"F Zattoni","year":"2023","unstructured":"Zattoni F, Pereira LJP, Marra G et al (2023) The impact of a second MRI and re-biopsy in patients with initial negative mpMRI-targeted and systematic biopsy for PIRADS\u2009\u2265\u20093 lesions. World J Urol. https:\/\/doi.org\/10.1007\/s00345-023-04578-7","journal-title":"World J Urol"},{"key":"6206_CR2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2100852","author":"M Eklund","year":"2021","unstructured":"Eklund M, J\u00e4derling F, Discacciati A et al (2021) MRI-targeted or standard biopsy in prostate cancer screening. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2100852","journal-title":"N Engl J Med"},{"key":"6206_CR3","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20200298","author":"JP Zawaideh","year":"2020","unstructured":"Zawaideh JP, Sala E, Pantelidou M et al (2020) Comparison of Likert and PI-RADS version 2 MRI scoring systems for the detection of clinically significant prostate cancer. Br J Radiol. https:\/\/doi.org\/10.1259\/bjr.20200298","journal-title":"Br J Radiol"},{"key":"6206_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.04.043","author":"V Kasivisvanathan","year":"2019","unstructured":"Kasivisvanathan V, Stabile A, Neves JB et al (2019) Magnetic resonance imaging-targeted biopsy versus systematic biopsy in the detection of prostate cancer: a systematic review and meta-analysis. Eur Urol. https:\/\/doi.org\/10.1016\/j.eururo.2019.04.043","journal-title":"Eur Urol"},{"key":"6206_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2022.07.025","author":"N Grivas","year":"2022","unstructured":"Grivas N, Lardas M, Espin\u00f3s EL et al (2022) Prostate cancer detection percentages of repeat biopsy in patients with positive multiparametric magnetic resonance imaging (Prostate Imaging Reporting and Data System\/Likert 3\u20135) and negative initial biopsy. A mini systematic review. Eur Urol. https:\/\/doi.org\/10.1016\/j.eururo.2022.07.025","journal-title":"Eur Urol"},{"key":"6206_CR6","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.18.20536","author":"JH Greer, Shih","year":"2019","unstructured":"Greer, Shih JH, Lay N et al (2019) Interreader variability of prostate imaging reporting and data system version 2 in detecting and assessing prostate cancer lesions at prostate MRI. AJR Am J Roentgenol. https:\/\/doi.org\/10.2214\/AJR.18.20536","journal-title":"AJR Am J Roentgenol"},{"key":"6206_CR7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801993","author":"V Kasivisvanathan","year":"2018","unstructured":"Kasivisvanathan V, Rannikko AS, Borghi M et al (2018) Mri-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa1801993","journal-title":"N Engl J Med"},{"key":"6206_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2016.06.079","author":"AB Rosenkrantz","year":"2016","unstructured":"Rosenkrantz AB, Verma S, Choyke P et al (2016) Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR. J Urol. https:\/\/doi.org\/10.1016\/j.juro.2016.06.079","journal-title":"J Urol"},{"key":"6206_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.08.003","author":"N Mottet","year":"2017","unstructured":"Mottet N, Bellmunt J, Bolla M et al (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. https:\/\/doi.org\/10.1016\/j.eururo.2016.08.003","journal-title":"Eur Urol"},{"key":"6206_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2017.04.101","author":"PF Fulgham","year":"2017","unstructured":"Fulgham PF, Rukstalis DB, Turkbey IB et al (2017) AUA policy statement on the use of multiparametric magnetic resonance imaging in the diagnosis, staging and management of prostate cancer. J Urol. https:\/\/doi.org\/10.1016\/j.juro.2017.04.101","journal-title":"J Urol"},{"key":"6206_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.03.027","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RCN, Briers E et al (2024) EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent. Eur Urol. https:\/\/doi.org\/10.1016\/j.eururo.2024.03.027","journal-title":"Eur Urol"},{"key":"6206_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.06.023","author":"FH Drost","year":"2020","unstructured":"Drost FH, Osses D, Nieboer D et al (2020) Prostate magnetic resonance imaging, with or without magnetic resonance imaging-targeted biopsy, and systematic biopsy for detecting prostate cancer: a cochrane systematic review and meta-analysis. Eur Urol. https:\/\/doi.org\/10.1016\/j.eururo.2019.06.023","journal-title":"Eur Urol"},{"key":"6206_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32401-1","author":"HU Ahmed","year":"2017","unstructured":"Ahmed HU, El-Shater BA, Brown LC et al (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet (Lond Engl). https:\/\/doi.org\/10.1016\/S0140-6736(16)32401-1","journal-title":"Lancet (Lond Engl)"},{"key":"6206_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14212","author":"A Maxeiner","year":"2018","unstructured":"Maxeiner A, Kittner B, Blobel C et al (2018) Primary magnetic resonance imaging\/ultrasonography fusion-guided biopsy of the prostate. BJU Int. https:\/\/doi.org\/10.1111\/bju.14212","journal-title":"BJU Int"},{"key":"6206_CR15","doi-asserted-by":"publisher","DOI":"10.4103\/aja2022112","author":"YH Wang","year":"2023","unstructured":"Wang YH, Liang C, Zhu FP et al (2023) Improving the understanding of PI-RADS in practice: characters of PI-RADS 4 and 5 lesions with negative biopsy. Asian J Androl. https:\/\/doi.org\/10.4103\/aja2022112","journal-title":"Asian J Androl"},{"key":"6206_CR16","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.17.18680","author":"AD Sheridan","year":"2018","unstructured":"Sheridan AD, Nath SK, Aneja S et al (2018) MRI-ultrasound fusion targeted biopsy of prostate imaging reporting and data system version 2 category 5 lesions found false-positive at multiparametric prostate MRI. AJR Am J Roentgenol: https:\/\/doi.org\/10.2214\/AJR.17.18680"},{"key":"6206_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-17260-6","author":"K Kornienko","year":"2022","unstructured":"Kornienko K, Reuter M, Maxeiner A et al (2022) Follow-up of men with a PI-RADS 4\/5 lesion after negative MRI\/ultrasound fusion biopsy. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-022-17260-6","journal-title":"Sci Rep"},{"key":"6206_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001424","author":"X Meng","year":"2021","unstructured":"Meng X, Chao B, Chen F et al (2021) Followup of men with PI-RADS\u2122 4 or 5 abnormality on prostate magnetic resonance imaging and nonmalignant pathological findings on initial targeted prostate biopsy. J Urol. https:\/\/doi.org\/10.1097\/JU.0000000000001424","journal-title":"J Urol"},{"key":"6206_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2021.09.015","author":"F Barletta","year":"2022","unstructured":"Barletta F, Stabile A, Mazzone E et al (2022) How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series. Urol Oncol-Semin Orig Investig. https:\/\/doi.org\/10.1016\/j.urolonc.2021.09.015","journal-title":"Urol Oncol-Semin Orig Investig"},{"key":"6206_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2020.12.004","author":"E Mazzone","year":"2021","unstructured":"Mazzone E, Stabile A, Pellegrino F et al (2021) Positive predictive value of prostate imaging reporting and data system version 2 for the detection of clinically significant prostate cancer: a systematic review and meta-analysis. Eur Urol Oncol. https:\/\/doi.org\/10.1016\/j.euo.2020.12.004","journal-title":"Eur Urol Oncol"},{"key":"6206_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001306","author":"KJ Park","year":"2020","unstructured":"Park KJ, Choi SH, Lee JS et al (2020) Risk stratification of prostate cancer according to PI-RADS\u00ae version 2 categories: meta-analysis for prospective studies. J Urol. https:\/\/doi.org\/10.1097\/JU.0000000000001306","journal-title":"J Urol"},{"key":"6206_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2020.04.001","author":"P Pepe","year":"2020","unstructured":"Pepe P, Pennisi M (2020) Negative biopsy histology in men with PI-RADS score 5 in daily clinical practice: incidence of granulomatous prostatitis. Clin Genitourin Cancer. https:\/\/doi.org\/10.1016\/j.clgc.2020.04.001","journal-title":"Clin Genitourin Cancer"},{"key":"6206_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2020.02.005","author":"A Stabile","year":"2020","unstructured":"Stabile A, Giganti F, Kasivisvanathan V et al (2020) Factors influencing variability in the performance of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer: a systematic literature review. Eur Urol Oncol. https:\/\/doi.org\/10.1016\/j.euo.2020.02.005","journal-title":"Eur Urol Oncol"},{"key":"6206_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13327","author":"H Cash","year":"2016","unstructured":"Cash H, G\u00fcnzel K, Maxeiner A et al (2016) Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging\/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure. BJU Int. https:\/\/doi.org\/10.1111\/bju.13327","journal-title":"BJU Int"},{"key":"6206_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99854-0","author":"C Wetterauer","year":"2021","unstructured":"Wetterauer C, Trotsenko P, Matthias MO et al (2021) Diagnostic accuracy and clinical implications of robotic assisted MRI-US fusion guided target saturation biopsy of the prostate. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-021-99854-0","journal-title":"Sci Rep"},{"key":"6206_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2012.08.025","author":"S Vourganti","year":"2012","unstructured":"Vourganti S, Rastinehad A, Yerram N et al (2012) Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. J Urol. https:\/\/doi.org\/10.1016\/j.juro.2012.08.025","journal-title":"J Urol"},{"key":"6206_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13247","author":"M Gayet","year":"2016","unstructured":"Gayet M, van der Aa A, Beerlage HP et al (2016) The value of magnetic resonance imaging and ultrasonography (MRI\/US)-fusion biopsy platforms in prostate cancer detection: a systematic review. BJU Int. https:\/\/doi.org\/10.1111\/bju.13247","journal-title":"BJU Int"},{"key":"6206_CR28","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000000359","author":"N Hanna","year":"2019","unstructured":"Hanna N, Wszolek MF, Mojtahed A et al (2019) Multiparametric magnetic resonance imaging-ultrasound fusion biopsy improves but does not replace standard template biopsy for the detection of prostate cancer. J Urol. https:\/\/doi.org\/10.1097\/JU.0000000000000359","journal-title":"J Urol"},{"key":"6206_CR29","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001232","author":"A Kinnaird","year":"2020","unstructured":"Kinnaird A, Sharma V, Chuang R et al (2020) Risk of prostate cancer after a negative magnetic resonance imaging guided biopsy. J Urol. https:\/\/doi.org\/10.1097\/JU.0000000000001232","journal-title":"J Urol"},{"key":"6206_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2018.03.007","author":"V Panebianco","year":"2018","unstructured":"Panebianco V, Barchetti G, Simone G et al (2018) Negative multiparametric magnetic resonance imaging for prostate cancer: what\u2019s next? Eur Urol. https:\/\/doi.org\/10.1016\/j.eururo.2018.03.007","journal-title":"Eur Urol"},{"key":"6206_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12175612","author":"W Malewski","year":"2023","unstructured":"Malewski W, Milecki T, Szempli\u0144ski S et al (2023) Prostate biopsy in the case of PIRADS 5-is systematic biopsy mandatory? J Clin Med. https:\/\/doi.org\/10.3390\/jcm12175612","journal-title":"J Clin Med"},{"key":"6206_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2022.01.008","author":"WG Brisbane","year":"2022","unstructured":"Brisbane WG, Priester AM, Ballon J et al (2022) Targeted prostate biopsy: umbra, penumbra, and value of perilesional sampling. Eur Urol. https:\/\/doi.org\/10.1016\/j.eururo.2022.01.008","journal-title":"Eur Urol"},{"key":"6206_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15184543","author":"J Morote","year":"2023","unstructured":"Morote J, Picola N, Mu\u00f1oz-Rodriguez J et al (2023) A diagnostic accuracy study of targeted and systematic biopsies to detect clinically significant prostate cancer, including a model for the partial omission of systematic biopsies. Cancers. https:\/\/doi.org\/10.3390\/cancers15184543","journal-title":"Cancers"},{"key":"6206_CR34","doi-asserted-by":"publisher","DOI":"10.1111\/bju.16816","author":"SA Fletcher","year":"2025","unstructured":"Fletcher SA, Alshak MN, Lee S et al (2025) Clinically significant prostate cancer detected by systematic biopsy in patients with MRI lesions. BJU Int. https:\/\/doi.org\/10.1111\/bju.16816","journal-title":"BJU Int"},{"key":"6206_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2019.01.030","author":"T Ullrich","year":"2019","unstructured":"Ullrich T, Arsov C, Quentin M et al (2019) Analysis of PI-RADS 4 cases: management recommendations for negatively biopsied patients. Eur J Radiol. https:\/\/doi.org\/10.1016\/j.ejrad.2019.01.030","journal-title":"Eur J Radiol"},{"key":"6206_CR36","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.240019","author":"B Salka","year":"2025","unstructured":"Salka B, Troost JP, Gaur S et al (2025) Clinical and imaging predictors of false-positive and false-negative results in prostate multiparametric MRI using PI-RADS version 2. Radiol Imaging Cancer. https:\/\/doi.org\/10.1148\/rycan.240019","journal-title":"Radiol Imaging Cancer"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06206-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06206-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06206-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T13:10:22Z","timestamp":1768569022000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06206-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6206"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06206-6","relation":{"references":[{"id-type":"doi","id":"10.2214\/AJR.17.18680","asserted-by":"subject"}]},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"3 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Adult Scientific Ethics Committee of the Servicio de Salud Metropolitano Oriente, Santiago, Chile. The study was conducted in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All participants provide written consent for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"98"}}